Detail akcie Ypsomed Holding online

Business Summary: Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, Ypsomed Holding AG revenues increased 37% to SF748.9M. Net income applicable to common stockholders increased 12% to SF87.5M. Revenues reflect Ypsomed Delivery Systems segment increase of 30% to SF501.1M, Ypsomed Diabetes Care segment increase of 57% to SF236.9M, Europe segment increase of 34% to SF446.8M, Rest of the World segment increase of 42% to SF156.7M.